Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Diseases | 1 | 2021 | 177 | 0.730 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 305 | 0.540 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 106 | 0.520 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 3869 | 0.350 |
Why?
|
| Fanconi Anemia | 2 | 2018 | 88 | 0.300 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2022 | 489 | 0.280 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 2796 | 0.230 |
Why?
|
| Hemoglobinopathies | 1 | 2023 | 24 | 0.230 |
Why?
|
| Pityriasis Lichenoides | 1 | 2022 | 2 | 0.220 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 47 | 0.210 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2022 | 16 | 0.210 |
Why?
|
| Lymphomatoid Papulosis | 1 | 2022 | 68 | 0.210 |
Why?
|
| Histiocytosis | 1 | 2022 | 54 | 0.210 |
Why?
|
| Blood Platelet Disorders | 1 | 2022 | 37 | 0.200 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 2 | 2018 | 41 | 0.200 |
Why?
|
| Hodgkin Disease | 2 | 2021 | 1429 | 0.190 |
Why?
|
| Biology | 1 | 2021 | 75 | 0.190 |
Why?
|
| Herpesvirus 4, Human | 3 | 2022 | 966 | 0.190 |
Why?
|
| Primary Myelofibrosis | 3 | 2018 | 831 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 88 | 0.190 |
Why?
|
| Hematologic Neoplasms | 2 | 2022 | 1870 | 0.190 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 339 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 310 | 0.170 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 35 | 0.170 |
Why?
|
| Tertiary Healthcare | 1 | 2019 | 44 | 0.170 |
Why?
|
| Burkitt Lymphoma | 1 | 2022 | 335 | 0.170 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 33 | 0.170 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 7 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 95 | 0.170 |
Why?
|
| Child | 14 | 2023 | 29154 | 0.170 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 197 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2020 | 176 | 0.160 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 10331 | 0.160 |
Why?
|
| Hematopoiesis | 2 | 2022 | 560 | 0.160 |
Why?
|
| Arthralgia | 1 | 2018 | 89 | 0.160 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 387 | 0.160 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 31 | 0.150 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 135 | 0.150 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1032 | 0.150 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 502 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 366 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 492 | 0.140 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 49 | 0.140 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2016 | 65 | 0.140 |
Why?
|
| Thrombopoietin | 1 | 2016 | 77 | 0.140 |
Why?
|
| Calreticulin | 1 | 2016 | 74 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 361 | 0.140 |
Why?
|
| Tumor Escape | 1 | 2018 | 251 | 0.140 |
Why?
|
| Megakaryocytes | 1 | 2016 | 104 | 0.140 |
Why?
|
| Anemia, Aplastic | 1 | 2017 | 214 | 0.140 |
Why?
|
| Receptors, Somatomedin | 1 | 2016 | 70 | 0.130 |
Why?
|
| CD8 Antigens | 1 | 2016 | 170 | 0.130 |
Why?
|
| CD5 Antigens | 1 | 2016 | 112 | 0.130 |
Why?
|
| Neoplasms | 1 | 2021 | 15193 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 1245 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 895 | 0.120 |
Why?
|
| Thrombocythemia, Essential | 1 | 2016 | 162 | 0.120 |
Why?
|
| Neutropenia | 1 | 2018 | 968 | 0.120 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.120 |
Why?
|
| Lymphoma | 1 | 2022 | 1467 | 0.120 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2017 | 2979 | 0.110 |
Why?
|
| Azacitidine | 1 | 2019 | 1149 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 1299 | 0.110 |
Why?
|
| Infant | 8 | 2020 | 13310 | 0.110 |
Why?
|
| Metformin | 1 | 2016 | 378 | 0.110 |
Why?
|
| Child, Preschool | 6 | 2019 | 16273 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 1439 | 0.100 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 679 | 0.100 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1664 | 0.100 |
Why?
|
| Leukemia | 1 | 2020 | 1635 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1681 | 0.100 |
Why?
|
| World Health Organization | 2 | 2022 | 316 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 846 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2017 | 3033 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1026 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2018 | 1616 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2016 | 1085 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 2864 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 2522 | 0.080 |
Why?
|
| Male | 14 | 2023 | 123000 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 1763 | 0.080 |
Why?
|
| Female | 14 | 2023 | 141928 | 0.080 |
Why?
|
| Gene Expression | 1 | 2016 | 3570 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 3552 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 7548 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 4654 | 0.070 |
Why?
|
| Prognosis | 4 | 2019 | 21713 | 0.070 |
Why?
|
| Mutation | 3 | 2022 | 15179 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 7222 | 0.070 |
Why?
|
| Syndrome | 2 | 2018 | 1351 | 0.060 |
Why?
|
| Young Adult | 3 | 2023 | 21445 | 0.060 |
Why?
|
| Adolescent | 6 | 2023 | 31252 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3230 | 0.060 |
Why?
|
| Hemolysis | 1 | 2023 | 127 | 0.060 |
Why?
|
| Phenotype | 3 | 2018 | 6295 | 0.050 |
Why?
|
| Haploidy | 1 | 2022 | 40 | 0.050 |
Why?
|
| Bilirubin | 1 | 2023 | 221 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 6915 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 48 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2022 | 86 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 217 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 335 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 995 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2021 | 436 | 0.040 |
Why?
|
| Prevalence | 2 | 2017 | 3260 | 0.040 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 26 | 0.040 |
Why?
|
| Celecoxib | 1 | 2018 | 200 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 234 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 661 | 0.040 |
Why?
|
| Consanguinity | 1 | 2018 | 114 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2002 | 518 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 77950 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2016 | 11965 | 0.040 |
Why?
|
| Philadelphia Chromosome | 1 | 2021 | 793 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 755 | 0.040 |
Why?
|
| Mice | 4 | 2022 | 34495 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 2018 | 201 | 0.040 |
Why?
|
| Poly I-C | 1 | 2016 | 29 | 0.040 |
Why?
|
| Aldehydes | 1 | 2016 | 44 | 0.040 |
Why?
|
| Inactivation, Metabolic | 1 | 2016 | 37 | 0.040 |
Why?
|
| Guanidines | 1 | 2016 | 60 | 0.040 |
Why?
|
| Reticulin | 1 | 2016 | 22 | 0.040 |
Why?
|
| Skin | 1 | 2022 | 1259 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 783 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 2422 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2016 | 225 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2016 | 44 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 15862 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 226 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2016 | 153 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 829 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 1048 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 153 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 1022 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 490 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 1664 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 1960 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1005 | 0.030 |
Why?
|
| Biopsy | 1 | 2022 | 3443 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1491 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1890 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 347 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 4109 | 0.030 |
Why?
|
| Animals | 4 | 2022 | 59536 | 0.030 |
Why?
|
| Middle Aged | 3 | 2018 | 86204 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 4971 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 3569 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 1581 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 1688 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 943 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2019 | 37905 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 998 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 70117 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2358 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2016 | 2084 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 2738 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 1242 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 4758 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 3045 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 2961 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5637 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 5710 | 0.020 |
Why?
|
| Diet | 1 | 2016 | 1440 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 5270 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 2967 | 0.020 |
Why?
|
| Apoptosis | 1 | 2022 | 7591 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 4744 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 5437 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 7226 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 14889 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 12926 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 8223 | 0.010 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2002 | 10 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 132 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2002 | 61 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 14551 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 6550 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1363 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 9180 | 0.010 |
Why?
|